Andel platform strengthens pharmacy benefits by giving employers an affordable way to include GLP-1s and other brand name medications.
Andel has raised $4.5M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Andel's investors include Seedcamp, Lightbank, SemperVirens Venture Capital, Bertelsmann Investments, Houghton Street Ventures.
Andel is headquartered in New York, United States.
Andel platform strengthens pharmacy benefits by giving employers an affordable way to include GLP-1s and other brand name medications.
Andel is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Andel — Funding & Investors." VCBacked, October 20, 2025, https://www.vcbacked.co/company/andel. Accessed July 20, 2026.
VCBacked. (2025). Andel — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/andel
{{cite web |title=Andel — Funding & Investors |url=https://www.vcbacked.co/company/andel |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated